Quinazoline derivatives

Details for Australian Patent Application No. 2004274227 (hide)

Owner AstraZeneca AB

Inventors Hennequin, Laurent Francois Andre; Bradbury, Robert Hugh; Barlaam, Bernard Christophe

Agent Davies Collison Cave

Pub. Number AU-B-2004274227

PCT Pub. Number WO2005/028469

Priority 03292309.6 19.09.03 EP; 04291248.5 14.05.04 EP

Filing date 15 September 2004

Wipo publication date 31 March 2005

Acceptance publication date 24 April 2008

International Classifications

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

30 March 2006 PCT application entered the National Phase

  PCT publication WO2005/028469 Priority application(s): WO2005/028469

24 April 2008 Application Accepted

  Published as AU-B-2004274227

21 August 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004274230-Derivatives of N-(1H-indazolyl)- and N- (1H-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (VR1) for the treatment of pain

2004274226-Process for the recovery of titanium dioxide from titanium-containing compositions